1Leung NW,Lai CL,Chang TT,et al.Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates:results after 3 years of therapy.Hepatology,2001,33:1527-1532.
2Liaw YF,Chien RN,Yeh CT,et al.Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.Hepatology,1999,30:567-572.
3Sun J,Wang Z,Ma S,et al.Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients:a single center experience.J Med Virol,2005,75:391-398.
4Xiong X,Flores C,Yang H,et al.Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro.Hepatology,1998,28:1669-1673.
5Peters MG,Hann Hw H,Martin P,et al.Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.Gastroenterology,2004,126:91-101.
